4.5 Article

Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications

期刊

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
卷 23, 期 2, 页码 299-308

出版社

SPRINGER
DOI: 10.1007/s11154-021-09655-z

关键词

Hypocalcemia; COVID-19; SARS-CoV-2; Calcium; Vitamin D; Bone

向作者/读者索取更多资源

COVID-19 patients may experience various endocrine manifestations, such as hypocalcemia, vertebral fractures, and vitamin D deficiency, which could negatively impact disease severity, inflammatory response, thrombotic markers, and mortality. Prompt assessment, monitoring, and calcium replacement are recommended to prevent severe complications.
COVID-19 extra-pulmonary features include several endocrine manifestations and these are becoming strongly clinically relevant in patients affected influencing disease severity and outcomes. At the beginning of COVID-19 pandemic no population data on calcium levels in patients affected were available and in April 2020 a first case of severe acute hypocalcemia in an Italian patient with SARS-CoV-2 infection was reported. Subsequently, several studies reported hypocalcemia as a highly prevalent biochemical abnormality in COVID-19 patients with a marked negative influence on disease severity, biochemical inflammation and thrombotic markers, and mortality. Also a high prevalence of vertebral fractures with worse respiratory impairment in patients affected and a widespread vitamin D deficiency have been frequently observed, suggesting an emerging Osteo-Metabolic Phenotype in COVID-19. To date, several potential pathophysiological factors have been hypothesized to play a role in determining hypocalcemia in COVID-19 including calcium dependent viral mechanisms of action, high prevalence of hypovitaminosis D in general population, chronic and acute malnutrition during critical illness and high levels of unbound and unsaturated fatty acids in inflammatory responses. Since hypocalcemia is a frequent biochemical finding in hospitalized COVID-19 patients possibly predicting worse outcomes and leading to acute cardiovascular and neurological complications if severe, it is reasonable to assess, monitor and, if indicated, replace calcium at first patient hospital evaluation and during hospitalization.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据